Join Dr. Peter McCaffrey of UTMB for a conversation on how robotics, AI and single-cell sequencing are reshaping the landscape of vaccine and drug development. Drawing on real-world experience with platforms like the Opentrons Flex, Dr. McCaffrey will explore the hidden value of automation—not just in speed or precision, but in how it reduces cognitive load and frees scientists to focus on innovation. From standardized workflows to smarter experiments, discover how automated labs at UTMB are enabling a new era of scalable, reproducible, and AI-ready science. 

Peter McCaffrey, MD, serves as chief AI officer and director of Laboratory Information Services, Pathology Informatics, and Division of Bioinformatics and Artificial Intelligence for the University of Texas Medical Branch at Galveston. He is a co-founder of Pragma Bio, which helps discover new medicines, and former CEO of Accetia, which develops next-generation sequencing analysis for small laboratories. He completed his medical degree at Johns Hopkins University School of Medicine and a master of science degree from Stanford University. He served as chief resident of Massachusetts General Hospital.